Do you lose weight on maintenance dose of Wegovy?
Do you lose weight on maintenance dose of Wegovy? Sometimes. In trials people kept losing after reaching it, but results vary and plateaus are common.
Key facts
- Semaglutide + B12 is $157/month (billed $157 every 4 weeks), charged only after a clinician approves it.
- Answer a few health questions online. A licensed clinician reviews them. If approved, it ships to your door.
- Adults 18 or older. A licensed clinician reviews your health history and decides whether treatment is appropriate for you. Availability depends on the state you live in.
If you are asking, "do you lose weight on maintenance dose of Wegovy," the best evidence says some people do, especially in the months after reaching the long term dose. Over time, many people plateau, meaning weight stabilizes even while you stay on treatment. This page explains what "maintenance dose" means in the Wegovy (semaglutide) prescribing information and what clinical trial data suggests about weight change over time. Vitals Vault can also help you ask dosing questions in PocketMD and discuss options with a licensed clinician if treatment is appropriate.
- Yes, some people continue losing weight on Wegovy maintenance, but plateaus are common over time.
- In STEP 1, average weight loss continued through 68 weeks with semaglutide 2.4 mg plus lifestyle.
- Maintenance is the long term dose after titration, chosen to balance benefit and tolerability.
- If weight loss stalls or side effects persist, your clinician can reassess the plan and dosing.
Do you keep losing weight on maintenance dose?
Why loss can continue
Reaching maintenance does not mean your body stops responding immediately. Appetite, fullness, and food cravings may keep shifting as you stay on a stable dose alongside nutrition and activity changes used in trials.
Why plateaus happen
As you lose weight, your body needs fewer calories to maintain itself, and weight loss often slows. Trials show weight loss tends to level off over time, even with ongoing treatment and lifestyle support.
What maintenance means
In the Wegovy label, maintenance refers to the long term dose used after gradual dose escalation. The label describes a maintenance dose of 2.4 mg once weekly, with 1.7 mg once weekly as an alternative if 2.4 mg is not tolerated.
What the evidence and label say
| Question | What sources support | What it means for you |
|---|---|---|
| Is maintenance a "keep it off" dose only? | No. In STEP 1, participants on semaglutide 2.4 mg plus lifestyle had mean weight loss that continued through week 68. | It is possible to keep losing after you reach maintenance, but the pace often slows over time. |
| What is the labeled maintenance dose? | Wegovy prescribing information describes a maintenance dose of 2.4 mg once weekly, or 1.7 mg once weekly if 2.4 mg is not tolerated. | Maintenance is not the same for everyone. Your prescriber chooses a dose based on benefits and side effects. |
| If you are not on Wegovy brand, does the label still apply? | Compounded semaglutide is not FDA-approved and does not have the Wegovy label. Dosing and instructions come from the prescribing clinician and dispensing pharmacy. | Use the Wegovy label as general education, but follow your own prescription directions and monitoring plan. |
What trials show over time
In the STEP 1 trial, adults with overweight or obesity receiving semaglutide 2.4 mg plus lifestyle intervention had greater mean weight loss than placebo through 68 weeks. This supports that weight loss can continue well after dose escalation, not only during the early titration phase.
Why your curve may differ
Trials include structured lifestyle counseling and regular follow up, which can affect outcomes. Medical conditions, other medications, sleep, stress, and how well side effects are managed can all influence whether you keep losing, plateau, or regain.
Safety still matters at maintenance
Even at a stable dose, GLP-1 medicines can cause side effects and have important warnings. The Wegovy label includes a boxed warning about thyroid C-cell tumors and warnings about pancreatitis, gallbladder disease, acute kidney injury, and hypoglycemia when used with insulin or insulin secretagogues.
Common side effects that can affect eating
The Wegovy label lists gastrointestinal side effects such as nausea, diarrhea, vomiting, constipation, and abdominal pain. If these persist, your clinician may adjust the plan to improve tolerability while keeping safety in focus.
When to talk to your clinician about maintenance
Weight loss stalls for months
A plateau can be normal, but if your weight has not changed for a sustained period, it is reasonable to review nutrition, activity, sleep, and medication adherence with your clinician. They can also check for other factors that may be limiting progress.
Side effects are ongoing
If nausea, vomiting, diarrhea, constipation, or abdominal pain continues or limits eating and hydration, contact your clinician. Persistent symptoms can sometimes signal dehydration or other complications that need evaluation.
Symptoms of pancreatitis
Seek medical care right away for severe abdominal pain that may radiate to the back, with or without vomiting. The Wegovy label warns about acute pancreatitis and recommends discontinuation if pancreatitis is suspected.
Gallbladder symptoms
Contact a clinician for right upper abdominal pain, fever, jaundice, or persistent nausea and vomiting. The Wegovy label warns that acute gallbladder disease has occurred with GLP-1 receptor agonists.
Kidney or dehydration concerns
If you have reduced urination, swelling, dizziness, or you cannot keep fluids down, get medical advice promptly. The label warns that acute kidney injury has occurred, sometimes in the setting of nausea, vomiting, or diarrhea.
Thyroid neck symptoms
Report a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. Wegovy has a boxed warning about thyroid C-cell tumors and is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN 2.
Practical tips while you are on maintenance
Track trends, not single weigh ins
Weekly averages can be more useful than day to day changes.
Plan for plateaus
A plateau can be expected as your body adapts to weight loss.
Prioritize protein and fiber
These can support fullness when appetite is lower.
Hydrate if GI symptoms occur
Dehydration risk rises with vomiting or diarrhea.
Bring questions to check ins
Ask about goals, side effects, and what monitoring you need.
Frequently Asked Questions
Do you lose weight on maintenance dose of Wegovy?
Some people do, especially after they first reach the long term dose, but weight loss often slows over time. In trials of semaglutide 2.4 mg with lifestyle support, average weight loss continued through 68 weeks, though individual results vary.
What is the maintenance dose for Wegovy?
The Wegovy prescribing information describes a maintenance dose of 2.4 mg once weekly, with 1.7 mg once weekly as an alternative if 2.4 mg is not tolerated. Your prescriber decides what is appropriate for you.
If I plateau on maintenance, does that mean Wegovy stopped working?
Not necessarily. Plateaus are common in weight management because your energy needs change as you lose weight. A clinician can help review lifestyle factors, adherence, side effects, and whether your overall plan still matches your goals.
Can you regain weight even if you stay on maintenance dose?
Yes, weight can fluctuate and some people regain weight despite ongoing treatment. Many factors can contribute, including changes in diet, activity, sleep, stress, and other medications. Discuss patterns with your clinician rather than making changes on your own.
Is compounded semaglutide the same as Wegovy?
No. Wegovy is a brand product, while compounded semaglutide is prepared by a licensed pharmacy for an individual prescription and is not FDA-approved. If you use compounded semaglutide through Vitals Vault, follow your prescriber and pharmacy instructions, not the Wegovy label.